US Healthcare Research and Quality Report: HAI’s NEED URGENT ATTENTION

Posted in These Categories: Studies and Hospital Acquired Infections feature-main

Medizone International, Inc. (Dually Traded: OTCBB/OTCQB: MZEI)
(http://medizoneint.com)

I was pleased to note this morning (April 14, 2010) that the New York Times reported on the Agency for Healthcare Research and Quality Report released yesterday which noted HOSPITAL ACQUIRED INFECTIONS NEED URGENT ATTENTION.

The Report focused on Hospital Acquired Infections, noting that the, “problem of hospital-acquired infections remains as resistant to cure as the germs that contribute to an estimated 100,000 deaths a year, according to an annual government study issued Tuesday.”

Despite threats of governmental sanctions, hospitals continue to see increased rates of post-operative bloodstream infections which increased by eight percent and catheter-associated urinary tract infections which increased by four percent.

There was no change in the incidence of bloodstream infections caused by the placement of catheters in central veins. The only positive news came from a 12 percent reduction in the rate of post-operative pneumonia.

Dr. Carolyn M. Clancy, the agency’s director, pointed out that projects across the country had shown remarkable success in reducing infection rates by adhering to basic standards for hand hygiene, disinfection of patients, sterile handling of equipment and proper use of antibiotics. But at many hospitals those successes have yet to overcome an entrenched medical culture.

‘Kathleen Sebelius, the secretary of health and human services, called the trend troubling but said the new health care law would ”help turn these numbers around.” Under the law, hospitals with high rates of infections will be penalized by the government starting in the 2015 fiscal year.

The agency has been releasing its Congressionally mandated reports on health care quality and disparities since 2003.

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospitals, sports training facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures. Successful decontamination by AsepticSure™ to the 6 log standard or greater has been demonstrated with C.difficile, E coli, Pseudomonas aeruginous, MRSA, VRE and Bacillius subtilis.

Medizone International, Inc.
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Fax: 415-868-2344

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Share and Enjoy: